top of page
AstraZeneca Secures CDSCO Approval for Durvalumab in Limited-Stage Small Cell Lung Cancer Treatment | iPharmaCenter
AstraZeneca has received approval from the Central Drugs Standard Control Organisation (CDSCO) for the import, sale, and distribution of...
Dr. Reddy’s Launches Toripalimab in India for Nasopharyngeal Carcinoma Treatment | iPharmaCenter
Dr. Reddy’s Laboratories has introduced Toripalimab in India, marking it as the first and only immuno-oncology therapy approved for...

Sanofi Secures Approval for Beyfortus in India to Shield Infants and Children from RSV | iPharmaCenter
Sanofi India announced the receipt of marketing authorization for Beyfortus (nirsevimab) from the Central Drugs Standard Control...


Indian Pharma News | 2024 | iPharmaCenter
May 21, 2024 Glenmark and BeiGene Collaborate to Market and Distribute Tislelizumab and Zanubrutinib in India Key Points: Tislelizumab:...

India Drug Approvals | 2024 | CDSCO | News | Updates | Media | iPharmaCenter
19th January, 2024 Tirzepatide Recommended alongside dietary adjustments and physical activity to enhance blood sugar management in...


India | Drug Approvals | Pharma News | 2024 | iPharmaCenter
January 03, 2024 AstraZeneca India Unveils Trastuzumab Deruxtecan for HER2-Positive Metastatic Cases AstraZeneca India has officially...


India new drug approvals | India Pharma | 2023 | CDSCO | Ministry of health news | iPharmaCenter
September 30, 2023 AstraZeneca received approval from CDSCO for palivizumab to prevent RSV infection. AstraZeneca approved palivizumab, a...


India | Healthcare News | Abbott to upgrade 75 PHCs | iPharmaCenter
September 26, 2023 Cipla initiated drone services to deliver medicines to difficult-to-reach terrains. Cipla Limited has unveiled an...


Department of Pharmaceuticals report emphasize on need of academia to meet industry's requirement
A study was conducted by the Department of Pharmaceuticals in India to assess the skills required for the Indian pharmaceutical industry....
bottom of page